Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs
Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs
Transcript
Fiser's up to10 billion dollar deal to buy MSA ended a fierce bidding war with Nova Nordisk. It's a move aimed at establishing Fizer in the very fast growing market for obesity drugs. Joining us now any first on CNBC interview to discuss the deal and who knows what else of course is company's chairman and CEO Albert Borla. Nice to have you here. Th... Read More
Install to Summarize YouTube Videos and Get Transcripts
Explore YouTube Video Summarizer or Get YouTube Transcript Extractor
Read in Other Languages (beta)
Share This Summary 📚
Summarize YouTube Videos and Get Video Transcripts with 1-Click
Download browser extensions on:
Try YouTube Summary with ChatGPT & Claude or YouTube Transcript Generator
Explore More Summaries from CNBC Television 📚
Trump administration weighs limits on proxy advisory firms & index fund managers: WSJ
CNBC Television
'Fast Money' traders talk Alphabet's record trading day
CNBC Television
BlackRock files application with SEC for staked ether ETF: CNBC Crypto World
CNBC Television
The reopening rally: Here's what you need to know
CNBC Television
Tracking inflation without CPI: Here's what to know
CNBC Television
Citi CEO Jane Fraser: Some of the hype of in AI is earned, some of it is 'exuberant'
CNBC Television
Summarize YouTube Videos and Get Video Transcripts with 1-Click
Download browser extensions on:
Try YouTube Summary with ChatGPT & Claude or YouTube Transcript Generator